You Searched For "eli lilly s tirzepatide" and got 20 results
Sort By:
3 mins read
Weight loss and diabetes drug Tirzepatide will cost Rs 80,000 per month in India
Tirzepatide is set to make its debut in the Indian market under the brand name Mounjaro for the tre…
2 mins read
Eli Lilly's weight-loss drug may prevent diabetes — but there's 1 unanswered question
People with pre-diabetes who took Zepbound or Mounjaro were 94% less likely to develop the disease,…
Hilary Brueck
2 mins read
Eli Lilly just halved the price of its weight-loss drug — declaring war on the booming market of knock-offs
Eli Lilly is now offering cheaper single-dose vials of its wildly popular weight-loss drug Zepbound…
Gabby Landsverk
1 min read
'Unbelievable demand' for weight-loss drugs sends Eli Lilly stock soaring 14% after earnings
"We just see unbelievable demand, and we're not even trying that hard to promote this drug. We're n…
Matthew Fox
2 mins read
Another perk of weight-loss drugs? Eli Lilly's Zepbound may alleviate sleep apnea, too
The new class of weight-loss drugs isn't just for diabetes and weight loss. Eli Lilly results from …
Hilary Brueck
3 mins read
Eli Lilly rides the weight-loss-drug wave to a new record high, and is now worth more than $700 billion
"We haven't scratched the surface in terms of how big the [GLP-1 weight loss] drugs are going to ge…
Matthew Fox
2 mins read
FDA just approved Eli Lilly's new weight-loss drug that's cheaper than Wegovy and stronger, too
Eli Lilly's tirzepatide weight-loss drug just got FDA approval. It is cheaper and possibly more eff…
Hilary Brueck
2 mins read
A new class of weight loss drugs is powering massive stock-market gains for Novo Nordisk and Eli Lilly
Eli Lilly now sports a market valuation of about $500 billion, making it the ninth largest US compa…
Matthew Fox
3 mins read
The difference between game-changer weight loss drugs semaglutide, tirzepatide, and liraglutide
Tirzepatide, marketed as Mounjaro for diabetes, could soon become the latest weight loss drug to be…
Amber Middleton
3 mins read
Why health insurers big and small are investing in delivering care
These are Insider's biggest healthcare stories for the week ending July 16.
Lydia Ramsey Pflanzer
3 mins read
New diabetes drug significant in fight against obesity, reveals new study
A weekly intake of a drug, approved to treat Type 2 diabetes, can provide substantial and sustained…
5 mins read
5 new weight-loss drugs to watch in the fight for the next Ozempic
Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar indu…
Gabby Landsverk
4 mins read
Weight-loss drugs are life-changing — and expensive. Here's one woman's solution.
A woman who started taking a popular weight loss medication through a clinical trial had to look fo…
Gabby Landsverk
1 min read
A new Ozempic rival helps patients lose fat, but keep their muscle the holy grail for a weight-loss drug
The Ozempic rival helped people lose weight while keeping more of their muscles intact. In a trial,…
Hilary Brueck
2 mins read
Viking Therapeutics' weight loss drug showed faster results in clinical trials than Ozempic or Wegovy. Here's how it works.
Viking Therapeutics' experimental drug helped patients lose weight faster than other popular GLP-1 …
Gabby Landsverk
3 mins read
The next big weight-loss drug is a huge leap forward from Ozempic
Using tirzepatide for weight loss was most effective with diet and exercise changes. It may be more…
Gabby Landsverk
3 mins read
People lost nearly 50 pounds on Zepbound — but gained more than half back when they stopped taking it
Zepbound can help people lose significant amounts of weight, but may need to be taken long-term to …
Gabby Landsverk
2 mins read
The next game-changing weight loss drug just moved closer to FDA approval
In a new study, patients on tirzepatide (Mounjaro) lost nearly 16% of their body weight in 16 month…
Gabby Landsverk
4 mins read
How weight-loss injections like Ozempic, Mounjaro, and 'triple G' compare in cost, results, and effectiveness
Popular weight-loss injections including tirzepatide, semaglutide, and liraglutide all work to regu…
Gabby Landsverk
2 mins read
Step aside Ozempic and Wegovy — 'landmark' trial results for weight-loss drug Mounjaro just dropped, and they look pretty impressive
A new study suggests Mounjaro is a stronger and more potent drug for weight loss than Ozempic — ove…